|
Delayed
NYSE
08:10:00 14/11/25 am AEDT
|
5-day change | 1st Jan Change | ||
| 31.61 USD | -0.37% |
|
+3.30% | +6.90% |
Investment objective
Putnam BioRevolutionTM ETF Seeks long-term capital appreciation by investing mainly in common stocks of companies of any size with a focus on those that Putnam believes offer the opportunity to capitalize on a convergence of technological developments in the life sciences sector.
Off-Hours Price |
Change |
YTD change |
Weight | ||
|---|---|---|---|---|---|
 | 605.00USD | +0.33% | +4.39% | 7.08% | |
| 204.96USD | -0.13% | -10.55% | 6.67% | |
| 377.00USD | -0.82% | +24.36% | 5.42% | |
| 224.13USD | -0.71% | +20.23% | 5.2% | |
| 330.24USD | -2.40% | +5.64% | 4.97% | |
| 85.36USD | -0.63% | +27.38% | 4.32% | |
| 249.88USD | +0.44% | +9.04% | 4.16% | |
| 807.09USD | -0.40% | +4.46% | 4.05% | |
| 1,121.93USD | -0.18% | +4.27% | 3.56% | |
In partnership with
Description
| US7467298052 |
|---|
- Stock Market
- ETF
- SYNB ETF
Select your edition
All financial news and data tailored to specific country editions
